Home Medicine Diagnostic, clinical and laboratory turnaround times in troponin T testing
Article
Licensed
Unlicensed Requires Authentication

Diagnostic, clinical and laboratory turnaround times in troponin T testing

  • Mari Ervasti , Karri Penttilä , Sirkku Siltari , Weronika Delezuch and Kari Punnonen
Published/Copyright: May 22, 2008

Abstract

Background: At present, measurements of troponins play a key role in the diagnosis of myocardial infarction. There is a consensus that a turnaround time (TAT) of 1 h or less should be achieved for cardiac marker assays. However, little is known about the real delays between the patient's arrival at the emergency department (ED) and the reporting of the test.

Methods: In the present study, the TATs of a cardiac marker, troponin T (TnT), were analyzed at a central laboratory at Kuopio University Hospital in a population consisting of 215 patients who were admitted to the hospital ED. Four specific time points were recorded: 1) the time of the patient's arrival to the ED, 2) the time of the ordering of the test, 3) the time when blood samples arrived at the laboratory, and 4) the time of completion and reporting of the test.

Results: The median diagnostic TAT from patient's arrival to the reporting of the TnT result was 122 min. The clinical median TAT was 46 min and the laboratory median TAT was 69 min. Laboratory TAT consisted of the preanalytical TAT at the ED (median 14 min), pre- and postanalytical TAT in the laboratory (median 40 min), and the analytical TAT (on average 10 min). The laboratory TAT was approximately half of the complete diagnostic TAT.

Conclusions: On the basis of this analysis, we propose new concepts for the TATs in the diagnostic process: diagnostic TAT which consists of clinical and laboratory TAT. The focus should be shifted from the analytical TAT to the diagnostic process as a whole.

Clin Chem Lab Med 2008;46:1030–2.


Corresponding author: Mari Ervasti, MD, Department of Clinical Chemistry, Kuopio University, Eastern Finland Laboratory Center, Post Box 1700, 70211 Kuopio, Finland Phone: +358-44-7178716, Fax: +358-17-173200,

Received: 2008-1-31
Accepted: 2008-2-29
Published Online: 2008-05-22
Published in Print: 2008-07-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. CCLM: Evolving to meet the needs of today's laboratory professionals and scientists
  3. Bacterial detection and blood product contamination
  4. Editorial: Rapid diagnostic tests to detect pathogenic microorganisms
  5. Reviews
  6. Rapid methods for diagnosis of bloodstream infections
  7. Validation criteria for nucleic acid amplification techniques for bacterial infections
  8. Incidence of bacterial transmission and transfusion reactions by blood components
  9. Strategies of bacteria screening in cellular blood components
  10. Methods for the detection of bacterial contamination in blood products
  11. Bacteria detection by flow cytometry
  12. Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products
  13. Microbial safety of cell based medicinal products – what can we learn from cellular blood components?
  14. Genetics and Molecular Diagnostics
  15. Screening for genetic heterogeneity in the interferon sensitivity determining region of the hepatitis C virus genome by polymerase chain reaction with melting curve analysis
  16. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population
  17. Genetic testing for adult-type hypolactasia in Italian families
  18. Improved real-time detection of the H63D and S65C mutations associated with hereditary hemochromatosis using a SimpleProbe assay format
  19. Easy detection of 5,10-methylenetetrahydrofolate reductase 1298A/C genotype by mutagenically separated PCR assay
  20. General Clinical Chemistry and Laboratory Medicine
  21. Mediterranean diet and plasma concentration of inflammatory markers in old and very old subjects in the ZINCAGE population study
  22. Plasma interleukin-1β, -6, -8 and tumor necrosis factor-α as highly informative markers of pelvic inflammatory disease
  23. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status
  24. Breath isoprene – aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study
  25. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration
  26. A comparison of two different assays for determining S-100B in serum and urine
  27. Diagnostic, clinical and laboratory turnaround times in troponin T testing
  28. Validation and Outcome Studies
  29. An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA
  30. A new general regression-based approach for method comparison studies
  31. Letters to the Editor
  32. Procalcitonin values in preeclamptic women are related to severity of disease
  33. Cross-reactivity between λ antiserum and fibrinogen: a double trap in interpretation of serum protein electrophoresis
  34. Erroneous result of white blood cell differential count in a patient with mixed hyperlipidemia
  35. Lack of association of GH T1663A variation and IGFBP3–202A/C polymorphism with risk of ischemic stroke in Chinese
  36. Erratum
  37. Quality planning and analytical quality requirements derived from biology
Downloaded on 19.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.185/pdf
Scroll to top button